Europe's generic drugmakers view challenges of national regulatory agencies

In its on-going effort to encourage cooperation and improve regulatory procedures in the region, the European Generic medicines Association (EGA) is holding its 6th EGA South East Europe Symposium in Vrsac, Serbia. This year’s symposium has been organized under the auspices of the Ministry of Health of the Republic of Serbia in cooperation with the Serbian Medicines and Medical Devices Agency (ALIMS), with technical support from the Association of Local Manufacturers of Medicinal Products and the leading Serbian generic medicines manufacturer Hemofarm.

Amongst the 200 delegates attending the symposium are top-level representatives from the medicines authorities and major generic medicine manufacturing companies throughout the region, including Albania, Bulgaria, Croatia, Bosnia and Herzegovina, Hungary, Kosovo under UNSCR 1244, Macedonia, Montenegro, Romania, Serbia, Slovenia, and Turkey.